FDA Inspection 1122735 — Dompe Farmaceutici S.p.A.
The FDA completed an inspection of Dompe Farmaceutici S.p.A. on February 19, 2020 in Milan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 19, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Milan (Italy)
Additional Details
Postmarket Adverse Drug Experience (PADE)